triiodothyronine has been researched along with Action Tremor in 11 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Old studies in animals and unblinded studies in a few hyperthyroid patients suggested that L -carnitine is a periferal antagonist of thyroid hormone action at least in some tissues." | 9.09 | Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. ( Benvenga, S; Campenni, A; Lapa, D; Ruggeri, RM; Russo, A; Trimarchi, F, 2001) |
| "Hypothermia and tremor responses of oxotremorine and eserine were studied in rats after several T3 treatment regimens." | 7.68 | Triiodothyronine (T3) modifies cholinergic-induced hypothermia and tremor in rats. ( Almeida, OM; Santos, R, 1993) |
| "thyroxine as treatment for hypothyroidism." | 6.63 | Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. ( Massey, JC; Smith, RN; Taylor, SA, 1970) |
| "Old studies in animals and unblinded studies in a few hyperthyroid patients suggested that L -carnitine is a periferal antagonist of thyroid hormone action at least in some tissues." | 5.09 | Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. ( Benvenga, S; Campenni, A; Lapa, D; Ruggeri, RM; Russo, A; Trimarchi, F, 2001) |
| "The effects of nadolol (or placebo) and carbimazole on thyrotoxic tremor were investigated in 18 thyrotoxic patients." | 5.05 | Tremor: an alternative approach for investigating adrenergic mechanisms in thyrotoxicosis? ( Abila, B; Kingswood, JC; Lazarus, JH; Marshall, RW; Richens, A; Wilson, JF, 1985) |
| "Intraperitoneal administration of fenvalerate, a synthetic pyrethroid, in male rats for 45 days in doses of 100 and 200 mg/kg body weight/day induced hyperexcitability, tremors and paralysis." | 3.69 | Fenvalerate-induced alterations in circulatory thyroid hormones and calcium stores in rat brain. ( Hans, RK; Kaul, PP; Rastogi, A; Seth, PK; Seth, TD; Srimal, RC, 1996) |
| "Hypothermia and tremor responses of oxotremorine and eserine were studied in rats after several T3 treatment regimens." | 3.68 | Triiodothyronine (T3) modifies cholinergic-induced hypothermia and tremor in rats. ( Almeida, OM; Santos, R, 1993) |
| "thyroxine as treatment for hypothyroidism." | 2.63 | Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. ( Massey, JC; Smith, RN; Taylor, SA, 1970) |
| " The beginning of therapy, dosage of drugs, length of application and results of treatment are critically evaluated, with special emphasis on the rate and time of remission, on the frequency of recurrences and on the success of additional treatments such as surgery and/or radioiodine application." | 1.31 | [Graves' disease. Clinical features and treatment results]. ( Amor, H; Crivellaro, C; Leimgruber, K; Oberhofer, R, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M | 1 |
| Miyauchi, A | 1 |
| Hisakado, M | 1 |
| Yoshioka, W | 1 |
| Kudo, T | 1 |
| Nishihara, E | 1 |
| Kihara, M | 1 |
| Ito, Y | 1 |
| Miya, A | 1 |
| Fukata, S | 1 |
| Nishikawa, M | 1 |
| Nakamura, H | 1 |
| CZERNIAK, P | 1 |
| CHAITCHIK, S | 1 |
| Almeida, OM | 1 |
| Santos, R | 1 |
| Kaul, PP | 1 |
| Rastogi, A | 1 |
| Hans, RK | 1 |
| Seth, TD | 1 |
| Seth, PK | 1 |
| Srimal, RC | 1 |
| Ishibashi, S | 1 |
| Nishizawa, Y | 1 |
| Taniguchi, Y | 1 |
| Kikumori, M | 1 |
| Nishimori, T | 1 |
| Iwakura, K | 1 |
| Sumi, N | 1 |
| Crivellaro, C | 1 |
| Oberhofer, R | 1 |
| Leimgruber, K | 1 |
| Amor, H | 1 |
| Benvenga, S | 1 |
| Ruggeri, RM | 1 |
| Russo, A | 1 |
| Lapa, D | 1 |
| Campenni, A | 1 |
| Trimarchi, F | 1 |
| Bauer, BA | 1 |
| Elkin, PL | 1 |
| Erickson, D | 1 |
| Klee, GG | 1 |
| Brennan, MD | 1 |
| Abila, B | 1 |
| Lazarus, JH | 1 |
| Kingswood, JC | 1 |
| Marshall, RW | 1 |
| Wilson, JF | 1 |
| Richens, A | 1 |
| Brochet, D | 1 |
| Martin, P | 1 |
| Soubrie, P | 1 |
| Simon, P | 1 |
| Smith, RN | 1 |
| Taylor, SA | 1 |
| Massey, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Desiccated Thyroid Extract Compared to Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-blind, Crossover Study.[NCT01739972] | 180 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for triiodothyronine and Action Tremor
| Article | Year |
|---|---|
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Administration, Oral; Adult; Asthenia; Biomarkers; Body Weight; Bone Density; Carnitine; Double-Blin | 2001 |
Tremor: an alternative approach for investigating adrenergic mechanisms in thyrotoxicosis?
Topics: Adrenergic beta-Antagonists; Adult; Carbimazole; Clinical Trials as Topic; Female; Humans; Hyperthyr | 1985 |
Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Synergism; Female; Humans; Hypothyroidism; Male; Middle | 1970 |
8 other studies available for triiodothyronine and Action Tremor
| Article | Year |
|---|---|
Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Topics: Adolescent; Adult; Aged; Appetite; Body Temperature; Cold Temperature; Defecation; Female; Hormone R | 2019 |
[HYPERTRIIODOTHYRONISM. CLINICAL AND LABORATORY FINDINGS; PRELIMINARY].
Topics: Asthenia; Chromatography; Emotions; Female; Headache; Humans; Hyperthyroidism; Hypothyroidism; Menst | 1964 |
Triiodothyronine (T3) modifies cholinergic-induced hypothermia and tremor in rats.
Topics: Acetylcholinesterase; Animals; Brain; Hyperthyroidism; Hypothermia; Male; Oxotremorine; Parasympatho | 1993 |
Fenvalerate-induced alterations in circulatory thyroid hormones and calcium stores in rat brain.
Topics: Animals; Brain; Brain Chemistry; Calcium; Hyperkinesis; Injections, Intraperitoneal; Insecticides; M | 1996 |
[Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 9-week recovery test].
Topics: Animals; Body Weight; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intrav | 1995 |
[Graves' disease. Clinical features and treatment results].
Topics: Antithyroid Agents; Disease-Free Survival; Female; Graves Disease; Humans; Iodine Radioisotopes; Mal | 2001 |
Symptomatic hyperthyroidism in a patient taking the dietary supplement tiratricol.
Topics: Aged; Aged, 80 and over; Anxiety; Dietary Supplements; Fatigue; Female; Humans; Hyperthyroidism; Med | 2002 |
Effects of triiodothyronine on the 5-hydroxytryptophan-induced head twitch and its potentiation by antidepressants in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Clenbuterol; Dose-Response Relationship, Drug; | 1985 |